CompletedNCT07181122
Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Observational studyAges 18+TürkiyeDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Ankara and 1 more locationSee all locations and recruitment
Study information
Study start dateStarted: October 22, 2025
- Recruitment status
- Completed
- Enrollment listed in the registry
- 230
- Sponsor
- Ankara Etlik City Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Türkiye
- Age range
- Over 18 Years
- Official registry ID
- NCT07181122
- Official title
Show the full official title
Prospective Observational Evaluation of Quality of Life, Functional Status, and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer Undergoing Androgen Receptor Pathway Inhibitor Therapy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ankara, Türkiye · Türkiye
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ankara Etlik City Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Androgen Receptor Pathway Inhibitors (ARPIs).
Who was this study for?
Listed age limits: from 18 years.
